05:15 PM EDT, 10/07/2024 (MT Newswires) -- Dundee (DC-A.TO) after trade Monday said it received board approval from TauRX Pharmaceuticals for the sale of 8,000 shares to a private investor at $125 per share.

Proceeds to Dundee stood at $1 million, the company said, adding that the transaction is now complete, and it still holds 1,007,008 shares of TauRx.

Dundee's Class A shares closed down $0.04 to $1.51 on the Toronto Stock Exchange.